SC 13G/A | 2022-02-14 | Boxer Capital, LLC | Matinas BioPharma Holdings, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | Boxer Capital, LLC | Matinas BioPharma Holdings, Inc. | 11,478,634 | 5.8% | EDGAR |
SC 13G/A | 2021-02-12 | Vivo Capital IX, LLC | Matinas BioPharma Holdings, Inc. | 1,176,974 | 0.6% | EDGAR |
SC 13G/A | 2020-02-14 | Boxer Capital, LLC | Matinas BioPharma Holdings, Inc. | 10,188,312 | 6.3% | EDGAR |
SC 13G/A | 2020-02-13 | Vivo Capital IX, LLC | Matinas BioPharma Holdings, Inc. | 1,826,015 | 0.9% | EDGAR |
SC 13G | 2019-03-26 | Vivo Opportunity, LLC | Matinas BioPharma Holdings, Inc. | 825,000 | 0.7% | EDGAR |
SC 13G/A | 2019-02-14 | Lorenzo Jennifer | Matinas BioPharma Holdings, Inc. | 7,483,771 | 6.2% | EDGAR |
SC 13G/A | 2019-02-14 | Boxer Capital, LLC | Matinas BioPharma Holdings, Inc. | 5,642,858 | 5.0% | EDGAR |
SC 13G | 2018-11-08 | Boxer Capital, LLC | Matinas BioPharma Holdings, Inc. | 7,142,858 | 7.0% | EDGAR |
SC 13G | 2017-07-03 | Lorenzo Jennifer | Matinas BioPharma Holdings, Inc. | 4,900,000 | 5.1% | EDGAR |
SC 13D | 2017-03-22 | Lorenzo Jennifer | Matinas BioPharma Holdings, Inc. | 15,396,760 | 24.5% | EDGAR |